LNTH

Lantheus Holdings Inc.

Price

$100.48

return (12m)

82.19%

p/e

23.83

p/bv

5.00

DIVIDEND YIELD

0.00%

LNTH price

Lantheus Holdings

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LNTH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.52%

3 months

6.36%

1 year

82.19%

2 years

2.68%

5 years

302.08%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LNTH

Valuation

P/E

23.83

Sector -2.19

Industry 1.21

P/BV

5.00

Sector 2.22

Industry 2.11

P/Revenue (PSR)

4.22

Sector 2.01

Industry 0.78

EV/EBITDA

53.89

Sector -17.81

Industry -25.30

EV/EBIT

66.21

Sector -26.72

Industry -18.04

P/EBITDA

13.92

Sector 0.36

Industry 0.18

P/EBIT

17.14

Sector -3.34

Industry 1.26

P/Total Assets

2.72

Sector 1.23

Industry 0.86

P/Net Current Assets

-86.53

Sector -27.35

Industry -12.37

P/Working Capital

9.49

Sector -4.54

Industry -49.48

EPS

4.24

Sector -0.87

Industry -0.55

BVPS

20.18

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

60.14%

Sector 43.36%

Industry 31.53%

EBITDA Margin

31.25%

Sector -323.65%

Industry -73.39%

EBIT Margin

25.44%

Sector -194.57%

Industry -11.94%

Operating Margin

19.43%

Sector -24.37%

Industry -9.87%

Net Profit Margins

17.69%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.16

Sector 0.12

Industry 0.22

Profitability

ROE

20.99%

Sector -33.82%

Industry -37.56%

ROA

11.40%

Sector -29.63%

Industry -17.56%

ROIC

20.29%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.06

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-0.19

Sector -1.47

Industry -31.86

Net Debt / EBIT

-0.23

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.02

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.43

Sector 0.14

Industry 0.51

Equity/Assets

0.54

Sector 0.42

Industry 0.25

Liabilities/Assets

0.46

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

29.63%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Lantheus Holdings ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$100.48

Fair Value

$43.88

Upside Return potential.

-56.33%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LNTH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LNTH Lantheus Holdings Inc.	$100.48	79.52%	0.00%	23.83	5.00	20.99%	17.69%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%
DXCM DexCom Inc.	$89.88	11.21%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.28	17.85%	0.00%	52.70	4.94	9.37%	15.43%
BDX Becton Dickinson and Company	$187.60	-0.85%	2.30%	53.25	2.05	3.85%	4.05%
IMRA Imara Inc.	$0.00	-100.00%	92.02%	65.05	1.13	1.74%	0.00%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$163.04	13.40%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.40	26.40%	1.45%	48.10	10.90	22.66%	26.71%
SNN Smith & Nephew PLC	$29.30	-16.53%	2.61%	11.16	2.43	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LNTH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Lantheus Holdings

Lantheus Holdings Inc.

Average Investor10 user rating

4.0 (2 people)

United States

19 years

Founded: 2007

2015

Time since IPO - 11 years

595

Employees

Lantheus Holdings Inc. (United States) is listed on the Nasdaq and has a market capitalization of $6.56 billion, with shareholders equity totaling $1.31 billion.

The company employs approximately 595 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Lantheus Holdings Inc. reported $1.56 billion in revenue, generating net income of $275.31 million.

Key financial metrics include a P/E ratio of 23.83, a price-to-book (P/B) ratio of 5.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LNTH.

Market cap

$6.56 billion

Net worth

$1.31 billion

$1,311,780,000.00

Assets

$2.41 billion

$2,414,660,000.00

Total Shares Outstanding

65.00 million

65,000,000

Average Daily Trading Volume

$1.33 million

$1,334,990.00

Sector

Health

Industry

Medical Supplies and Equipment

LNTH

LNTH revenue and profits

Financial Results LNTH

DRAG THE FRAME TO SEE MORE DATA

LNTH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87